Phase 4 N=11,648 The Dual Antiplatelet Therapy Study (DAPT Study)
Coronary Artery Disease
Primary: MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT — 4.34; 5.92 percentage of patients (KM estimate) — p=<0.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=24 Control of Tourniquet Pain With an Axillary Ring of Subcutaneous Local Anesthetic
Application Site Discomfort · Medical Device Discomfort
Primary: Time in Minutes That Tq Remained Inflated — 30.5; 22.4 Minutes
Phase 4 N=110 Recovery After Laparoscopic Hysterectomy With Deep Neuromuscular Blockade and Low Intra-abdominal Pressure
Neuromuscular Blockade · Pain · Laparoscopy
Primary: Shoulder Pain — 14; 30 participants
Phase 4 N=52 Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®)
Chronic Migraine
Primary: Change From Baseline in the Assessment of Chronic Migraine Impacts (ACM-I) Questionnaire Total Score — 50.5; 47.2; -25.2; -20.5 Scores on a Scale
Phase 4 N=208 Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults
Influenza
Primary: Percentage of Participants Reporting Solicited Injection-site and Solicited Systemic Reactions Following Vaccination With the 2014-2015 Formulation of Fluzone®…
Phase 4 N=60 Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
Influenza
Primary: Percentage of Participants Reporting Solicited Injection-site or Systemic Reactions Following Vaccination With the 2014-2015 Formulation of Fluzone® Quadrivalent…
Phase 4 N=57 A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)
Immune Thrombocytopenic Purpura
Primary: Set of Antibodies Most Frequently Bound to Red Blood Cells (RBCs) in Subjects Experiencing Clinically Significant Intravascular Hemolysis
Phase 4 N=20 Treatment of Insomnia and Glucose Metabolism
Sleep · Insomnia · Insulin Resistance
Primary: Plasma Glucose Level at the 120-minute Time Point of a 75g Oral Glucose Tolerance Test
Phase 4 N=402 A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years
Influenza, Human
Primary: The Frequency and Intensity of Fever Events Occurring During the 7 Days After Each Administration of CSL TIV Vaccine. — 8.2; 4.1; 2.1; 2.1 Percentage of subjects
Phase 4 N=178 A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers
Peptic Ulcer
Primary: Number of Participants in Whom Peptic Ulcer Was Healed — 66; 66 participants
Phase 4 N=767 A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older
Influenza
Primary: Number of Subjects Reporting Solicited Adverse Events (AEs) After Vaccination. — 134; 122; 74; 72 participants
Phase 4 N=69 Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis
Osteoporosis
Primary: Change From Baseline to 3 Months in Mineralizing Surface (MS) /Bone Surface (BS) in the Cancellous Compartment (CC) of the Iliac Crest Bone Biopsies — 12.43; -2.51…
Phase 4 N=100 Effect of Fentanyl on Coughing and Recovery After Anesthesia With an LMA Laryngeal Mask Airway)for Airway Management
Ambulatory Surgery · Coughing
Primary: Incidence of Coughing — 10; 6 participants
Phase 4 N=10 Performance of Junctional Tourniquets in Normal Human Volunteers
Hemorrhage
Primary: Effectiveness at Stopping Distal Pulse — 97; 27; 83; 93 percentage of participants
Phase 4 N=343 Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
Diabetes · Diabetes Mellitus, Type 2
Primary: Change in Fructosamine From Start of Ramadan to End of Ramadan — -13.2; -14.9 umol/L